Four years Follow-up of Patients with Irritable Bowel Syndrome

1. ÅSHILD FARESJÖ,EWA GRODZINSKY,CLAES HALLERT, TOOMAS TIMPKA. Patients with irritable bowel syndrome are more burdened by co-morbidity and worry about serious diseases than healthy controls- eight years follow-up of IBS patients in primary care. BMC Public Health 2013, 13:832 http://www.biomedcentral.com/1471-2458/13/832.10.1186/1471-2458-13-832Search in Google Scholar

2. DEVANARAYANA NM, METTANANDA S, LIYANARACHCHI C, NANAYAKKARA N, MENDIS N, PERERA N, RAJINDRAJITH S. Abdominal pain-predominant functional gastrointestinal diseases in children and adolescents: prevalence, symptomatology, and association with emotional stress. J Pediatr Gastroenterol Nutr, 2011, 53:659-665.10.1097/MPG.0b013e3182296033Search in Google Scholar

3. ZHOU H, YAO M, CHENG G-Y, CHEN Y-P, LI D-G. Prevalence and associated factors of functional gastrointestinal disorders and bowel habits in Chinese adolescents: a school-based study. J Pediatr Gastroenterol Nutr2011, 53:168-173.10.1097/MPG.0b013e3182125388Search in Google Scholar

4. 4. RUTTEN JM,VLIEGER AM,FRANKENHUIS C,GEORGE EK,GROENEWEG M,NORBRUIS OF,TJON A TEN W,VAN WERING H,DIJKGRAAF MG,MERKUS MP,BENNINGA MA. Gut-directed hypnotherapy in children with irritable bowel syndrome or functional abdominal pain (syndrome): a randomized controlled trial on self exercises at home using CD versus individual therapy by qualified therapists. BMC Pediatr. 2014 Jun 4;14:140. doi: 10.1186/1471-2431-14-140.10.1186/1471-2431-14-140Search in Google Scholar

5. CHOUNG RS, LOCKE GR III. Epidemiology of IBS.Gastroenterol. Clin North Am 2011, 40:1-10.10.1016/j.gtc.2010.12.006Search in Google Scholar

6. HERSCHBACH P, HENRICH G, VON RAD M. Psychological factors in functional gastrointestinal disorders: characteristics of the disorder or of the illness behaviour? Psychosom Med 1999, 61:148-153.10.1097/00006842-199903000-00005Search in Google Scholar

7. KOLOSKI NA, TALLEY NJ, BOYCE PM. Predictors of health care seeking for irritable bowel syndrome and non-ulcer dyspepsia: a critical review of the literature on symptoms and psychological factors. Am J Gastroenterol2001, 96:1340-1349.10.1111/j.1572-0241.2001.03789.xSearch in Google Scholar

8. VAN DULMEN AM, FENNIS JEM, MOKKINK HGA, VAN DER VELDEN HGM, BLEIJENBERG G. Doctor’s perceptions of patient’s cognitions and complaints in irritable bowel syndrome at an out-patients clinic. J Psychosom Res 1994, 38:581-590.10.1016/0022-3999(94)90055-8Search in Google Scholar

9. FARESJÖ Å, GRODZINSKY E, JOHANSSON S, WALLANDER MA, TIMPKA T, ÅKERLIND I. A population based case- control study of work and psychosocial problems in patients with irritable bowel syndrome-women are more seriously affected than men. Am J Gastroenterol 2007, 102(2):371-379.10.1111/j.1572-0241.2006.01012.xSearch in Google Scholar

10. HERSCHBACH P, HENRICH G, VON RAD M. Psychological factors in functional gastrointestinal disorders: characteristics of the disorder or of the illness behaviour? Psychosom Med 1999, 61:148-153.10.1097/00006842-199903000-00005Search in Google Scholar

11. TALLEY NJ, SPILLER R. Irritable bowel syndrome: a little understood organic bowel disease? Lancet, 2002, 360:555-564.10.1016/S0140-6736(02)09712-XSearch in Google Scholar

12. MERTZ H, NALIBOFF B, MUNKATA J, NIAZI N, MAYER EA. Altered rectal perceptions are a biological marker of patients with irritable bowel syndrome. Gastroenterology, 1995, 109:40-52.10.1016/0016-5085(95)90267-8Search in Google Scholar

13. HEYMANN-MÖNNIKES I, ARNOLD R, FLORIN I, HERDA C, MELFSEN S, MÖNNIKES H. The combinations of medical treatment plus multicomponent behavioural therapy is superior to medical treatment alone in the therapy of irritable bowel syndrome. Am J Gastroenterol, 2000, 95:981-994.10.1016/S0002-9270(00)00729-2Search in Google Scholar

14. GUTHRIE E, CREED F, DAWSON D, TOMENSON B. A randomized trial of psychotherapy in patients with refractory irritable bowel syndrome. Br. J Psychiatry, 1993, 163:315-321.10.1192/bjp.163.3.315Search in Google Scholar

15. MARKOWITZ M, HARRIS W, RICCI JF, HARRISON C, GORDON SH, WENTZ A. Comorbid conditions in patients with irritable bowel syndrome: data from a national IBS awareness registry. Gastroenterology, 2001, 120 (SUPPL1):105. 10.1016/S0016-5085(08)81146-8Search in Google Scholar

16. HUDSON JI, GOLDENBERG DL, POPE HG, KECK PE, SCHLESINGER L. Co-morbidity of fibromyalgia with medical and psychiatric disorders. Am J Med. 1992, 92:363-367.10.1016/0002-9343(92)90265-DSearch in Google Scholar

17. LONGSTRETH GF, WOLDE-TSADIK G. Irritable bowel-type symptoms in HMO examinees; prevalence, demographics, and clinical correlates. Dig Dis Sci1993, 38:1581-1589.10.1007/BF01303163Search in Google Scholar

18. SPERBER AD, CARMEL S, ATZMON Y, WEISBERG I, SHALIT Y, NEUMAN L, FICH A, BUSKILA D. The sense of coherence index and the irritable bowel syndrome: a cross-sectional comparison among irritable bowel syndrome patients with and without coexisting fibromyalgia, irritable bowel syndrome non-patients, and controls. Scand J Gastroenterol, 1999, 34:259-263.10.1080/00365529950173654Search in Google Scholar

19. ÅSHILD FARESJÖ, EWA GRODZINSKY, CLAES HALLERT AND TOOMAS TIMPKA. Patients with irritable bowel syndrome are more burdened by co-morbidity and worry about serious diseases than healthy controls- eight years follow-up of IBS patients in primary care. BMC Public Health 2013, 13:832 doi:10.1186/1471-2458-13-832.10.1186/1471-2458-13-832Search in Google Scholar

20. JONES R, LATIONOVIC J, CHARLTON J, GULLIFORD M. Psychical and psychological co-morbidity in irritable bowel syndrome: a matched cohort study using the general practice research database. Aliment Pharmacol Ther, 2006, 24:879-886.10.1111/j.1365-2036.2006.03044.xSearch in Google Scholar

21. WHITHEAD WE, PALSSON O, JONES KR. Systematic review of the co-morbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology, 2002, 122:1140-1156.10.1053/gast.2002.32392Search in Google Scholar

22. MACLEAN EW, PALSSON OS, TURNER MJ, WHITEHEAD WE. Development and validation of new disease-specific measures of somatisation and co-morbidity in IBS. J Psychosom Res 2, 012, 73:352-355.10.1016/j.jpsychores.2012.08.007Search in Google Scholar

23. VANDVIK PO, LYDERSEN S, FARUP PG. Prevalence, co-morbidity and impact of irritable bowel syndrome in Norway. Scand J Gastroenterol, 2006, 41:650-656.10.1080/00365520500442542Search in Google Scholar

24. HAUG TANGEN T, MYKLETUN A, DAHL A. Are anxiety and depression related to gastrointestinal symptoms in the general populations? Scand J Gastroenterol, 2002, 37:294-298.10.1080/003655202317284192Search in Google Scholar

25. FARESJÖ Å, GRODZINSKY E, JOHANSSON S, WALLANDER MA, TIMPKA T, ÅKERLIND I. Psychosocial factors at work and in everyday life are associated with irritable bowel syndrome. Eur J Epidemiol, 2007, 22(7):473-480.10.1007/s10654-007-9133-2Search in Google Scholar

26. SPERBER AD, ATZMON Y, NEUMANN L, WEISBERG I, SHALIT Y, ABU-SHAKRAH M, FICH A, BUSKILA D. Fibromyalgia in the irritable bowel syndrome: studies of prevalence and clinical implications. Am J Gatroenterol, 1999, 94:3541-3546.10.1111/j.1572-0241.1999.01643.xSearch in Google Scholar

27. SLOTH H, JÖRGENSEN LS. Predictors for the course of chronic non-organic upper abdominal pain. Scand J Gastroenterol, 1989, 24:440-444.10.3109/00365528909093072Search in Google Scholar

28. VANDEVIK PO, WILHELMSEN I, IHLEBÄCK C, FARUP PG. Co-morbidity of irritable bowel syndrome in general practice: a striking feature with clinical implications. Aliment Pharmacol Ther, 2004, 20:1195-1203.10.1111/j.1365-2036.2004.02250.xSearch in Google Scholar

29. CHANG F, LU CL. Irritable bowel syndrome and migraine; bystanders or partners? J Neurogastenterol Motil, 2013, 19:301-311.10.5056/jnm.2013.19.3.301Search in Google Scholar

30. AZPIROZ F, DAPOIGNY M, PACE F, MÜLLER-LISSNER S, COREMANS G, WHORWELL P, STOCKBRUGGER RW, SMOUT A. Nongastrointestinal disorders in the irritable bowel syndrome. Digestion, 2000, 62:66-72.10.1159/000007780Search in Google Scholar

31. VANDEVIK PO, WILHELMSEN I, IHLEBÄCK C, FARUP PG. Co-morbidity of irritable bowel syndrome in general practice: a striking feature with clinical implications. Aliment Pharmacol Ther, 2004, 20:1195-1203. 10.1111/j.1365-2036.2004.02250.xSearch in Google Scholar